GBT - Global Blood Therapeutics Inc.
Close
68.49
0.010 0.015%
Share volume: 0
Last Updated: Tue 04 Oct 2022 10:00:01 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$68.48
0.01
0.02%
Summary score
16%
Profitability
0%
Dept financing
6%
Liquidity
74%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.38%
Return on assets
-9.36%
Return on sales
-1928.6%
Return on invested capital
-27.01%
Total debt ratio
11.72%
Debt ratio change over timeo
-1.14%
Current Ratio
14.39%
Quick Ratio
8.59%
Cash Position Ratio
7.9%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.75%
Return on assets
-10.02%
Return on sales
-1928.6%
Return on invested capital
-86.4%
Total debt ratio
24.37%
Debt ratio change over timeo
-1.3%
Current Ratio
10.34%
Quick Ratio
8.59%
Cash Position Ratio
5.33%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-10.66%
Return on assets
-7.21%
Return on sales
-165.19%
Return on invested capital
-90.74%
Total debt ratio
31.3%
Debt ratio change over time
-1.49%
Current Ratio
8.56%
Quick Ratio
8.17%
Cash Position Ratio
5.54%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-88.55%
Return on assets
-89.7%
Return on sales
2013.93%
Return on invested capital
27.06%
Total debt ratio
-114.33%
Debt ratio change over time
-1.14%
Current Ratio
-16.75%
Quick Ratio
-11.42%
Cash Position Ratio
-9.37%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GBT | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -10.38% | 0% | 0% | 29.06% |
| Return on assets | -9.36% | 0% | 0% | -9.75% |
| Return on sales | -1928.6% | 0% | 0% | -1469.44% |
| Return on invested capital | -27.01% | 0% | 0% | 47.78% |
| Profitability | 0% | 0% | 50% | 50% |
| Total debt ratio | 11.72% | 0% | 0% | 183.15% |
| Debt ratio change over time | -1.14% | 0% | 0% | 19.02% |
| Dept financing | 2% | 0% | 0% | 50% |
| Current Ratio | 10.34% | 0% | 0% | 5.9% |
| Quick Ratio | 8.59% | 0% | 0% | 5.9% |
| Cash Position Ratio | 5.33% | 0% | 0% | 5.68% |
| Liquididy | 75% | 0% | 0% | 33% |
| Short-term ratios | GBT | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -12.75% | 0% | 0% | -16.12% |
| Return on assets | -10.02% | 0% | 0% | -14.95% |
| Return on sales | -1928.6% | 0% | 0% | -3498.94% |
| Return on invested capital | -86.4% | 0% | 0% | 96.56% |
| Profitability | 0% | 0% | 75% | 25% |
| Total debt ratio | 24.37% | 0% | 0% | 79.61% |
| Debt ratio change over time | -1.3% | 0% | 0% | 0.09% |
| Dept financing | 8% | 0% | 0% | 50% |
| Current Ratio | 10.34% | 0% | 0% | 5.9% |
| Quick Ratio | 8.59% | 0% | 0% | 5.9% |
| Cash Position Ratio | 5.33% | 0% | 0% | 5.68% |
| Liquididy | 73% | 0% | 0% | 56% |